HeartSciences 

$0.07
29
-$0.05-42.72% Wednesday 18:59

Statistics

Day High
0.12
Day Low
0.12
52W High
0.12
52W Low
0.12
Volume
101
Avg. Volume
-
Mkt Cap
207,526.58
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16MarExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q2 2025
Q3 2025
Q4 2025
-2.61
-1.95
-1.29
-0.63
Expected EPS
-1.12
Actual EPS
-0.63

Financials

-219,125%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
8,000Revenue
-17.53MNet Income

Analyst Ratings

$8.00Average Price Target
The highest estimate is 8.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSCSW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of cardiovascular devices and diagnostics, directly competing with HSCS's heart testing technologies.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc specializes in medical devices for cardiac and vascular diseases, offering products that compete with HSCS's heart diagnostic solutions.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation provides innovative medical solutions, including cardiovascular devices that compete with HSCS's offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical device segment, offers products for cardiovascular care, competing with HSCS's heart diagnostics.
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Royal Philips offers advanced cardiac diagnostics and monitoring solutions, competing with HSCS in the heart test market.
GE Aerospace
GE
Mkt Cap325.88B
General Electric, through its healthcare division, provides medical imaging and monitoring technologies for cardiovascular care, competing with HSCS.
Siemens
SIEGY
Mkt Cap224.45B
Siemens Healthineers offers a wide range of diagnostic imaging and laboratory diagnostics, including cardiovascular testing, competing with HSCS.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on diagnostics and medical imaging systems, including those for cardiovascular health, making it a competitor to HSCS.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a range of medical devices and software for health care, including products for cardiovascular support, competing with HSCS.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company offers medical devices and technology, including for cardiovascular care, competing with HSCS's heart diagnostics.

About

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Show more...
CEO
Mr. Andrew Simpson
Employees
15
Country
US
ISIN
US42254E1120

Listings

0 Comments

Share your thoughts

FAQ

What is HeartSciences stock price today?
The current price of HSCSW is $0.07 USD — it has decreased by -42.72% in the past 24 hours. Watch HeartSciences stock price performance more closely on the chart.
What is HeartSciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange HeartSciences stocks are traded under the ticker HSCSW.
What is HeartSciences market cap?
Today HeartSciences has the market capitalization of 207,526.58
When is the next HeartSciences earnings date?
HeartSciences is going to release the next earnings report on July 22, 2026.
What is HeartSciences revenue for the last year?
HeartSciences revenue for the last year amounts to 8,000 USD.
What is HeartSciences net income for the last year?
HSCSW net income for the last year is -17.53M USD.
How many employees does HeartSciences have?
As of April 02, 2026, the company has 15 employees.
In which sector is HeartSciences located?
HeartSciences operates in the Health Care sector.
When did HeartSciences complete a stock split?
The last stock split for HeartSciences was on May 17, 2024 with a ratio of 1:100.
Where is HeartSciences headquartered?
HeartSciences is headquartered in Southlake, US.